Checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy

INTRODUCTION AND OBJECTIVE:Immune checkpoint inhibitors (ICIs) demonstrate impressive clinical benefit across a variety of cancers. NCCN guidelines for several cancers including renal cell carcinom...